Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2019-05-09 5:12 pm Purchase | 13G | MABVAX THERAPEUTICS HOLDINGS, INC. MBVX | OPKO HEALTH Inc OPK | 488,131 4.99% | 488,131 (New Position) | View |
| 2018-08-06 5:29 pm Sale | 13G | MABVAX THERAPEUTICS HOLDINGS, INC. MBVX | Honig Barry C | 447,195 4.99% | -761,709 (-63.01%) | View |
| 2018-07-25 06:15 am Sale | 13D | MABVAX THERAPEUTICS HOLDINGS, INC. MBVX | Stetson John | 447,195 4.99% | -757,157 (-62.87%) | View |
| 2018-03-02 5:07 pm Sale | 13D | MABVAX THERAPEUTICS HOLDINGS, INC. MBVX | HANSEN JOHN DAVID | 391,987 4.75% | -83,985 (-17.64%) | View |
| 2018-03-02 5:03 pm Purchase | 13D | MABVAX THERAPEUTICS HOLDINGS, INC. MBVX | HANSEN JOHN DAVID | 475,972 6.5% | 475,972 (New Position) | View |
| 2018-02-15 8:47 pm Unchanged | 13D | MABVAX THERAPEUTICS HOLDINGS, INC. MBVX | Honig Barry C | 1,208,904 4.99% | 0 (Unchanged) | View |
| 2018-02-12 7:45 pm Purchase | 13D | MABVAX THERAPEUTICS HOLDINGS, INC. MBVX | Honig Barry C | 1,208,904 4.99% | 817,256 (+208.67%) | View |
| 2018-02-12 5:23 pm Purchase | 13D | MABVAX THERAPEUTICS HOLDINGS, INC. MBVX | Stetson John | 1,204,352 4.99% | 349,670 (+40.91%) | View |